galsulfase

Ukraine

Drugs containing this active substance

  • NAGLAZIM®

    The drug is used for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome).

    Form: concentrate for infusion solution

    Active substance Dosage
    galsulfase 1 mg/ml

    ATC: A16AB08

    Manufacturer: AndersonBrecon (UK) Limited (labeling and secondary packaging of medicinal product)